ISSN: 0340-6245

Journal Home

Journal Guideline

Thrombosis and Haemostasis Q1 Unclaimed

Georg Thieme Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Thrombosis and Haemostasis is a journal indexed in SJR in Hematology with an H index of 188. It has an SJR impact factor of 1,97 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,97.

Thrombosis and Haemostasis focuses its scope in these topics and keywords: factor, human, clinical, atrial, protein, patients, expression, inhibition, thrombosis, validation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,97

SJR Impact factor

188

H Index

206

Total Docs (Last Year)

745

Total Docs (3 years)

9184

Total Refs

3116

Total Cites (3 years)

642

Citable Docs (3 years)

3,89

Cites/Doc (2 years)

44,58

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annals of Oncology Q1
CA - A Cancer Journal for Clinicians Q1
Blood Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients

A novel gene mutation in the 60s loop of human coagulation factor VII -inhibition of interdomain crosstalk

Fibrin glue for wound repair: facts and fancy

IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life

Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy

New developments in anticoagulants: Past, present and future

Circulating levels of inflammatory cytokines (IL-1beta and TNF-a), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?

Efficacy of AT in pre-eclampsia: a case-control prospective trial

Superoxide Anion and Hydroxyl Radical Release by Collagen-induced Platelet Aggregation - Role of Arachidonic Acid Metabolism

A Novel Platelet Activating Factor Antagonist, SM-12502, Attenuates Endotoxin-induced Disseminated Intravascular Coagulation and Acute Pulmonary Vascular Injury by Inhibiting TNF Production in Rats

SHOW MORE ARTICLES

Critical residues for ligand binding in blade 2 of the propeller domain of the integrin aIIb subunit

Neuraminidase Injections in Rabbits

Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during inflammation

Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss

The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis

Occurrence of Amphoterin (HMG1) as an Endogenous Protein of Human Platelets that Is Exported to the Cell Surface upon Platelet Activation

Activation-dependent surface expression of gC1qR/p33 on human blood platelets

Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium

Circulating platelet-derived microparticles in systemic lupus erythematosus

Localization of heparin and low-molecular-weight heparin in the rat kidney

Shear-Induced Platelet Aggregation in Normal Subjects and Stroke Patients

The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement